Heimdal Utbytte vs UBS Lux Equity Fund Biotech USD

Security

Heimdal Utbytte N
Fee

1.29%
ISIN

NO0012948852
Holdings

24

Security

UBS Lux Equity Fund Biotech USD P-acc
Fee

2.25%
ISIN

LU0069152568
Holdings

10

Fund Holdings

We have information about 28 holdings in Heimdal Utbytte, where the largest holding is SpareBank (5.1), followed by SpareBank 1 SMN (4.97) and DNB (4.9). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Heimdal Utbytte and UBS Lux Equity Fund Biotech USD.

Heimdal Utbytte	UBS Lux Equity Fund Biotech USD
1. SpareBank 1 Sør-Norge ASA 5.1 %	1. Regeneron Pharmaceuticals Inc 10.04 %
2. SpareBank 1 SMN 4.97 %	2. Vertex Pharmaceuticals Inc 9.35 %
3. DNB Bank 4.9 %	3. Moderna Inc 9.21 %
4. Storebrand 4.82 %	4. Alnylam Pharmaceuticals Inc 6.96 %
5. Gjensidige Forsikring 4.81 %	5. AbbVie Inc 5.53 %
6. Orkla Foods AS 4.46 %	6. Gilead Sciences Inc 4.66 %
7. Aker BP 4.43 %	7. Amgen Inc 4.3 %
8. Kongsberg Gruppen ASA 4.41 %	8. BioNTech SE 4.13 %
9. Protector Forsikring ASA 4.27 %	9. Karuna Therapeutics Inc 3.75 %
10. Equinor ASA 4.19 %	10. Royalty Pharma Plc 3.37 %
11. SpareBank 1 Nord-Norge 4.12 %	-
12. Sparebanken Vest 4 %	-
13. Mowi 3.6 %	-
14. Norconsult ASA 3.11 %	-
15. Telenor ASA 3.1 %	-
16. Schibsted A 2.64 %	-
17. SalMar ASA 2.03 %	-
18. Pareto Bank ASA 1.95 %	-
19. Subsea 7 SA 1.79 %	-
20. Essity B 1.65 %	-
21. Atea 1.56 %	-
22. Securitas B 1.46 %	-
23. Bouvet ASA 1.37 %	-
24. AstraZeneca 1.33 %	-

The list of fund holdings was last updated on June 5, 2025.